Lf nanodispersion is a hypoglycemic product with a potent α-glucosidase and pancreatic lipase inhibitor effect.

Abstract

Authors

• Ariadna Lafourcade Prada
  Pharmacy Department, Faculty of Natural Sciences, University of Oriente, Patricio Lumumba s/n, Santiago de Cuba, CP 84500 Santiago de Cuba, Cuba.
• Hady Keita
  Division of Postgraduate Studies in Health, University of La Sierra del Sur, Calle Guillermo Rojas Mijangos S/N, Esq. Av. Universidad Colonial, Miahuatlán de Porfirio Díaz, C.P. 70800 Oaxaca, Mexico.
• Tatiane Pereira de Souza
  Laboratory of Innovation and Development in Pharmaceutical Technology (LIDETEF), Faculty of Pharmaceutical Sciences, Federal University of Amazonas, Ave Rodrigo Otavio Ramos, 6200, Barrio Coroado, CEP 69077-000 Manaus, AM, Brazil.
• Emerson Silva Lima
  Laboratory of Biological Activity, Pharmaceutical Sciences Faculty, Federal University of Amazonas, Ave. Rodrigo Otavio Ramos 6200, Coroado, CEP 69077-000 Manaus, AM, Brazil.
• Leonard Domingo Rosales Acho
  Laboratory of Biological Activity, Pharmaceutical Sciences Faculty, Federal University of Amazonas, Ave. Rodrigo Otavio Ramos 6200, Coroado, CEP 69077-000 Manaus, AM, Brazil.
• Márcia de Jesus Amazonas da Silva
  Laboratory of Biological Activity, Pharmaceutical Sciences Faculty, Federal University of Amazonas, Ave. Rodrigo Otavio Ramos 6200, Coroado, CEP 69077-000 Manaus, AM, Brazil.
• José Carlos Tavares Carvalho
  Drug Research Laboratory, Federal University of Amapá, Rodovia Juscelino Kubitschek, km 2, Jardim Marco Zero, CEP: 68903-419 Macapá, AP, Brazil.
• Jesus Rafael Rodriguez Amado
  Pharmacy Department, Faculty of Natural Sciences, University of Oriente, Patricio Lumumba s/n, Santiago de Cuba, CP 84500 Santiago de Cuba, Cuba.

Keywords

No keywords available for this article.

External Resources